- Corporate Officers - H
- Henwood Geraldine
Insider Trading History of Henwood Geraldine
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Henwood Geraldine since 2006.
This trader's CIK number is 1236451.
At the time of last reporting, Henwood Geraldine was the President and CEO of Baudax Bio, Inc.. (stock ticker symbol BXRX).
Also see all insider trading activities at Baudax Bio, Inc..
Note that in the past
HENWOOD GERALDINE also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Auxilium Pharmaceuticals Inc (AUXL) by Henwood Geraldine
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | AUXL | 1,000 | $6,430 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Recro Pharma, Inc. (REPH) by Henwood Geraldine
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | REPH | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2020 | REPH | 0 | $0 | 80,000 | $657,600 | 5,000 | $0 |
| 2019 | REPH | 0 | $0 | 144,806 | $1,287,180 | 128,500 | $305,045 |
| 2018 | REPH | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2017 | REPH | 0 | $0 | 0 | $0 | 31,100 | $0 |
| 2015 | REPH | 4,500 | $40,136 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alkermes Plc. (ALKS) by Henwood Geraldine
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | ALKS | 0 | $0 | 40,000 | $1,916,120 | 40,000 | $616,200 |
| 2013 | ALKS | 0 | $0 | 20,000 | $633,540 | 20,000 | $268,800 |
| 2012 | ALKS | 0 | $0 | 88,000 | $1,544,594 | 88,000 | $925,408 |
Yearly summary of insider trading at Baudax Bio, Inc. (BXRX) by Henwood Geraldine
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | BXRX | 14,200 | $9,789 | 0 | $0 | 0 | $0 |
| 2020 | BXRX | 0 | $0 | 0 | $0 | 19,070 | $0 |
Yearly summary of insider trading at Map Pharmaceuticals, Inc. (MAPP) by Henwood Geraldine
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | MAPP | 0 | $0 | 10,000 | $250,000 | 10,000 | $119,400 |
| 2012 | MAPP | 0 | $0 | 5,240 | $78,600 | 5,240 | $10,270 |
| 2010 | MAPP | 0 | $0 | 21,764 | $306,292 | 21,764 | $23,776 |
| 2009 | MAPP | 0 | $0 | 16,250 | $142,447 | 16,250 | $10,416 |
Insider trading activities at 5 companies by Henwood Geraldine:
1. Auxilium Pharmaceuticals Inc (AUXL)
2. Recro Pharma, Inc. (REPH)
3. Alkermes Plc. (ALKS)
4. Baudax Bio, Inc. (BXRX)
5. Map Pharmaceuticals, Inc. (MAPP)
Table 1. Insider trading of Auxilium Pharmaceuticals Inc (AUXL) by Henwood Geraldine
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-03-10 | AUXL | Buy | 1,000 | 6.43 | 6,430 |
Table 2. Insider trading of Recro Pharma, Inc. (REPH) by Henwood Geraldine
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-01-18 | REPH | Option Ex | 5,000 | .00 | 0 |
| 2020-04-17 | REPH | Sale | 80,000 | 8.22 | 657,600 |
| 2020-01-18 | REPH | Option Ex | 5,000 | .00 | 0 |
| 2019-05-13 | REPH | Option Ex | 123,500 | 2.47 | 305,045 |
| 2019-05-13 | REPH | Sale | 144,806 | 8.89 | 1,287,180 |
| 2019-01-18 | REPH | Option Ex | 5,000 | .00 | 0 |
| 2018-01-18 | REPH | Option Ex | 5,000 | .00 | 0 |
| 2017-09-28 | REPH | Option Ex | 31,100 | .00 | 0 |
| 2015-06-05 | REPH | Buy | 3,950 | 8.83 | 34,878 |
| 2015-06-08 | REPH | Buy | 550 | 9.56 | 5,258 |
Table 3. Insider trading of Alkermes Plc. (ALKS) by Henwood Geraldine
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-01-15 | ALKS | Sale | 40,000 | 47.90 | 1,916,120 |
| 2014-01-15 | ALKS | Option Ex | 40,000 | 15.40 | 616,200 |
| 2013-08-29 | ALKS | Option Ex | 20,000 | 13.44 | 268,800 |
| 2013-08-29 | ALKS | Sale | 20,000 | 31.68 | 633,540 |
| 2012-08-24 | ALKS | Option Ex | 20,000 | 11.84 | 236,800 |
| 2012-08-24 | ALKS | Sale | 20,000 | 17.94 | 358,840 |
| 2012-08-27 | ALKS | Option Ex | 20,000 | 11.44 | 228,800 |
| 2012-08-27 | ALKS | Sale | 20,000 | 17.80 | 355,980 |
| 2012-02-23 | ALKS | Sale | 1,600 | 17.32 | 27,704 |
| 2012-02-22 | ALKS | Sale | 46,400 | 17.29 | 802,070 |
| 2012-02-23 | ALKS | Option Ex | 1,600 | 8.98 | 14,368 |
| 2012-02-22 | ALKS | Option Ex | 46,400 | 9.60 | 445,440 |
Table 4. Insider trading of Baudax Bio, Inc. (BXRX) by Henwood Geraldine
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-09-22 | BXRX | Buy | 8,200 | .58 | 4,797 |
| 2021-05-07 | BXRX | Buy | 6,000 | .83 | 4,992 |
| 2020-01-27 | BXRX | Option Ex | 19,070 | .00 | 0 |
Table 5. Insider trading of Map Pharmaceuticals, Inc. (MAPP) by Henwood Geraldine
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-02-28 | MAPP | Option Ex | 10,000 | 11.94 | 119,400 |
| 2013-02-28 | MAPP | Sale | 10,000 | 25.00 | 250,000 |
| 2012-11-23 | MAPP | Option Ex | 5,240 | 1.96 | 10,270 |
| 2012-11-23 | MAPP | Sale | 5,240 | 15.00 | 78,600 |
| 2010-10-27 | MAPP | Option Ex | 9,764 | 1.52 | 14,860 |
| 2010-10-27 | MAPP | Sale | 9,764 | 15.66 | 152,884 |
| 2010-08-05 | MAPP | Option Ex | 12,000 | .74 | 8,916 |
| 2010-08-05 | MAPP | Sale | 12,000 | 12.78 | 153,408 |
| 2009-11-18 | MAPP | Option Ex | 16,250 | .64 | 10,416 |
| 2009-11-18 | MAPP | Sale | 16,250 | 8.77 | 142,447 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Henwood Geraldine
(President and CEO of Baudax Bio, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.